Back to results
US 6,319,892 B1Granted
Use of recombinant myelin protein for treating T-cell-mediated autoimmune diseases of the peripheral nervous system
OwnerRalf Gold, Andreas Weishauptinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of recombinant myelin protein for treating T cell-mediated autoimmune diseases of the peripheral nervous system.
Claims6
A method for treating T cell mediated autoimmune peripheral nervous system disease, comprising administering to a subject in need thereof a sufficient amount of at least one recombinant myelin protein to alleviate said T cell mediated autoimmune peripheral nervous system disease.
A method for making a composition for treating a T cell mediated autoimmune disease, comprising admixing at least one recombinant myelin protein and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.